Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Janet Nyawira Oyieko · Sankore

United States Army Medical Research Directorate - Africa

Janet Nyawira Oyieko

ORCID, self-asserted

ORCID 0000-0001-7343-9127

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it.

Publications

9

Citations

88

h-index

6

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

3

Read this before using these figures

The graph holds no coverage record for this country.

Publications

4 works in the graph, newest first.

Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi
2025The Lancet Global HealthJournalOpen access9 citations10.1016/s2214-109x(25)00415-2
Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study
2025The Lancet Global HealthJournalOpen access8 citations10.1016/s2214-109x(25)00096-8
Incidence rates of malaria, meningitis, and mortality in children younger than 5 years: a prospective cohort study in Ghana and Kenya before the roll-out of the RTS,S/AS01E malaria vaccine from 2016 to 2022
2025The Lancet Global HealthJournalOpen access4 citations10.1016/s2214-109x(25)00022-1
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial
2023The Lancet Respiratory MedicineJournalOpen access25 citations10.1016/s2213-2600(23)00263-1